Passage Bio Inc (PASG)

Currency in USD
4.6200
+0.1200(+2.67%)
Real-time Data·

Passage Bio (PASG) Stock Forecast & Price Target

Advanced Equity Forecast
Overall Consensus
Buy
1 Buy
2 Hold
0 Sell
Data based on a poll of the past 3 months

Analysts 12-Month Price Target

Average 15.5000
(+235.50% Upside)

Past 24 Months

12-Month Forecast

Analyst Ratings

Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Guggenheim
Hold---DowngradeJun 10, 2026
TD Cowen
Hold---DowngradeApr 21, 2026
Oppenheimer
Buy15.00+224.68%30.00MaintainApr 21, 2026
Wedbush
Hold8.00+73.16%-DowngradeApr 21, 2026
Chardan
Hold7.00+51.52%21.00DowngradeApr 21, 2026

Fair Value

Average
Upside
Uncertainty
Spread
Market Range
52 weeks
$3
$20
Analyst Targets
2 analysts
$8
$23
Fair Value
4 models

FAQ

Is PASG a Buy, Sell, or Hold?

The consensus rating for Passage Bio is "Buy", based on insights from 2 analysts. 1 analysts recommend buying the stock, 0 suggest selling, and 2 recommend holding.

What Is the Price Target for Passage Bio (PASG) According to Analysts?

According to projections from 2 analysts, the average 12-month price target for Passage Bio is 15.5000 USD, with a high estimate of 23 USD and a low estimate of 8 USD.

What Is PASG’s Potential Upside or Downside, Based on the Analysts’ Average Price Target?

Passage Bio has a potential Upside of +235.50%, based on analysts’ average price target.

How Has Passage Bio Stock Performed Over the Past 52 Weeks?

The Passage Bio 52-week range spans from 3.2900 to 20.0000.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.